Advanced Net Receivables from 2010 to 2026

ADVB Stock   0.30  0.01  2.24%   
Advanced Biomed's Net Receivables is increasing over the years with stable fluctuation. Net Receivables is expected to dwindle to 6,802. From 2010 to 2026 Advanced Biomed Net Receivables quarterly data regression line had arithmetic mean of  11,776 and r-squared of  0.05. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
7.2 K
Current Value
6.8 K
Quarterly Volatility
39 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Advanced Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 64.6 K or Interest Income of 64.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0048. Advanced financial statements analysis is a perfect complement when working with Advanced Biomed Valuation or Volatility modules.
  
Build AI portfolio with Advanced Stock
Check out the analysis of Advanced Biomed Correlation against competitors.

Latest Advanced Biomed's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Advanced Biomed Common over the last few years. It is Advanced Biomed's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Advanced Biomed's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Pretty Stable
   Net Receivables   
       Timeline  

Advanced Net Receivables Regression Statistics

Arithmetic Mean11,776
Geometric Mean1,334
Coefficient Of Variation330.82
Mean Deviation17,734
Median419.00
Standard Deviation38,956
Sample Variance1.5B
Range162.1K
R-Value0.22
Mean Square Error1.5B
R-Squared0.05
Significance0.41
Slope1,659
Total Sum of Squares24.3B

Advanced Net Receivables History

2026 6802.38
2025 7160.4
2024 7956.0
2023 6324.0
2022 4814.0
2021162.5 K

About Advanced Biomed Financial Statements

Advanced Biomed stakeholders use historical fundamental indicators, such as Advanced Biomed's Net Receivables, to determine how well the company is positioned to perform in the future. Although Advanced Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Advanced Biomed's assets and liabilities are reflected in the revenues and expenses on Advanced Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Advanced Biomed Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables7.2 K6.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:
Check out the analysis of Advanced Biomed Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.17)
Return On Assets
(0.35)
Return On Equity
(1.65)
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.